12:00 AM
 | 
Sep 13, 2010
 |  BC Week In Review  |  Company News  |  Deals

Abbott deal

Abbott said it will retain the influenza vaccine portion of the pharmaceutical business of Solvay S.A....

Read the full 68 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >